Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

99.48 -0.75 (-0.75%)
Streaming Delayed Price Updated: 10:37 AM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Moderna Is Expecting Massive Growth Over the Next Decade. Is the Stock a No-Brainer Buy?
The stock has been struggling this year, but could things soon be getting brighter for Moderna? 
Via The Motley Fool
Looking Into Moderna's Recent Short Interest
Via Benzinga
Does This Message From Moderna Mean Bad News for Novavax?
So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market. 
Via The Motley Fool
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
I favor holding onto these players for the long term to truly benefit from their earnings potential. 
Via The Motley Fool
Price Targets
Along with giving buy, sell, or hold ratings on the stocks they cover, Wall Street analysts also provide investors with a price target. 
Via Talk Markets
Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
As the U.S. 
Via Benzinga
Exposures COVID-19
Check Out What Whales Are Doing With MRNA
Via Benzinga
Here Are 15 New Reasons to Be Bullish About Moderna Stock
With its first big successes drawing to a close, new products are on the horizon. 
Via The Motley Fool
Moderna Unusual Options Activity For September 15
Via Benzinga
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of. 
Via InvestorPlace
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
All three companies should benefit from increased COVID-19 booster sales. 
Via The Motley Fool
Exposures COVID-19
Beware! 3 Value Stocks Waving Massive Red Flags Right Now.
Traps are omnipresent today. Don't fall for low ratios and cheap stats, but look for underlying potential. Heed these value stocks to avoid. 
Via InvestorPlace
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These stocks could take off in the years to come. 
Via The Motley Fool
Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now.
A range of worries are pulling these Nasdaq stocks to sell lower and clouding the outlook for their share prices. 
Via InvestorPlace
Is Moderna Stock a Top Buy?
Wall Street is bullish on the biotech's novel pipeline. 
Via The Motley Fool
This 1 Number May Completely Change Your Opinion About Moderna
Moderna shares look dirt cheap considering the company's prospects. 
Via The Motley Fool
3 Stocks to Avoid Like the Plague Right Now: MRNA, GPS, PTON
The good economic times of the past few years appear to be ending. As such, it's time to exit these three stocks to avoid. 
Via InvestorPlace
Amazon, Moderna And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly higher on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
2 Stocks That Sank Hard on Monday
Investors were generally in wait-and-see mode, but not with certain individual stocks. 
Via The Motley Fool
Why Moderna Stock Is Sinking Today
Moderna, Inc. (NASDAQ: MRNA) shares are trading lower Monday alongside other vaccine stocks amid a selloff after the sector gained amid ri 
Via Benzinga
Stocks Sluggish As Oil, Bond Yields Rise
Stocks are stagnant to kick off the week, with all three major indexes cautiously higher midday. 
Via Talk Markets
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
2 Top Trends to Invest $500 In Right Now
Early investors in these trends may reap the rewards over time. 
Via The Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
Catalysts on the horizon could drive gains in these top stocks. 
Via The Motley Fool
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get... 
Via Benzinga
Exposures COVID-19 Product Safety
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now. 
Via InvestorPlace
Why Moderna Stock Is Rising Today
Moderna, Inc. (NASDAQ: MRNA) shares are trading higher after the EMA Committee for Medicinal Products for Human Use adopted an opinion recommending authorization of the company's updated COVID-19 
Via Benzinga
Exposures COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respiratory Vaccines, Latent/Other Vaccines, Oncology Therapeutics,  
Via Benzinga
Exposures COVID-19
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.